Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings

  • Rudilla Salvador, Francesc
  • Franco Jarava, Clara
  • García Prat, Marina
  • Martín Nalda, Andrea
  • Rivière, Jacques
  • Vidal Pérez, Francisco
  • Cuscó Martín, Ivon
  • Serra Juhe, Clara
  • Baz Redón, Noelia
  • García-Patos Briones, Vicente
  • Pujol-Borrell, Ricardo
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
  • Fernández Cancio, Mónica
  • Aguiló Cucurull, Aina
Inmunodeficiencias primarias; Secuenciación de próxima generación; Secuenciación clínica del exoma, Immunodeficiències primàries; Seqüenciació de propera generació; Seqüenciació clínica d’exomes, Primary immunodeficiencies; Next generation sequencing; Clinical exome sequencing, Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders., This study was funded by Instituto de Salud Carlos III, grants PI14/00405 and PI17/00660, cofinanced by the European Regional Development Fund (ERDF).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing, Expected and Unexpected Findings

  • Rudilla, Francesc|||0000-0002-3099-067X
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Rivière, Jacques
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Mongay, Laura
  • Vidal, Francisco|||0000-0001-8089-4945
  • Solanich, Xavier|||0000-0002-2572-2187
  • Irastorza, Iñaki
  • Santos-Pérez, Juan Luis
  • Tercedor Sánchez, Jesús
  • Cusco, Ivon|||0000-0003-2104-9332
  • Serra, Clara
  • Baz-Redón, Noelia|||0000-0003-1704-3413
  • Fernández Cancio, Mónica|||0000-0003-1872-3488
  • Carreras, Carmen
  • Vagace, Manuel
  • García-Patos Briones, Vicente|||0000-0003-1654-6035
  • Pujol-Borrell, Ricardo|||0000-0001-7833-675X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Fortuny Guasch, Claudia
  • Rey, Lourdes
  • Bunney, Tom D.
  • Alsina Manrique, Laia|||0000-0002-3559-0018
  • Esteve-Sole, Ana|||0000-0002-0542-0587
  • Bull, Daniel
  • Anton, Maria Carmen
  • Basagaña Torrentó, Maria|||0000-0002-5478-5945
  • Casals, Ferran|||0000-0002-8941-0369
  • Deyà-Martínez, Ángela|||0000-0002-8026-7674
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Gimeno Martínez, Ramón
  • Juan, Manel|||0000-0002-3064-1648
  • Martinez-Banaclocha, Helios
  • Martinez-Garcia, Juan J.
  • Mensa-Vilaro, Anna|||0000-0001-7541-9672
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Martín Begué, Nieves|||0000-0003-0365-1266
  • Rudilla, Francesc|||0000-0002-3099-067X
  • Estivill, Xavier|||0000-0002-0723-2256
  • García-Patos Briones, Vicente|||0000-0003-1654-6035
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Katan, Matilda
  • Pelegrín, Pablo|||0000-0002-9688-1804
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Vicente, Asun
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
The online version of this article (10.1007/s10875-020-00794-7) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia, Implications for Genetic Counseling

  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Blasco-Pérez, Laura|||0000-0001-6483-5742
  • Paramonov, Ida
  • Antolín, María|||0000-0001-5623-6862
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
X-linked agammaglobulinemia (XLA) is a clinically and genetically well-defined immunodeficiency and the most common form of agammaglobulinemia. It is characterized by susceptibility to recurrent bacterial infections, profound hypogammaglobulinemia, and few or no circulating B cells. XLA is caused by mutations in the BTK gene, which encodes Bruton's tyrosine kinase (BTK). Because of its X-linked recessive inheritance pattern, XLA virtually only affects males, and the mother is the carrier of the mutation in 80-85% of the males with this condition. In the remaining 15-20% of the cases, the affected male is considered to have a de novo mutation. Here, we present the case of a child with a diagnosis of XLA caused by a missense mutation in the BTK gene (c.494G.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluating the Genetics of Common Variable Immunodeficiency, Monogenetic Model and Beyond

  • de Valles-Ibáñez, Guillem
  • Esteve-Sole, Ana|||0000-0002-0542-0587
  • Piquer, Mònica
  • González-Navarro, Europa Azucena|||0000-0003-3310-5557
  • Hernandez-Rodriguez, Jessica|||0000-0002-0402-286X
  • Laayouni, Hafid|||0000-0003-1297-5078
  • González Roca, Eva|||0000-0002-1126-0321
  • Plaza-Martin, Ana María
  • Deyà-Martínez, Ángela|||0000-0002-8026-7674
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Del Pino Molina, Lucía|||0000-0003-2392-097X
  • Cusco, Ivon|||0000-0003-2104-9332
  • Codina Solà, Marta|||0000-0002-5382-413X
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Solís-Moruno, Manuel|||0000-0001-7407-8896
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Bosch, Elena|||0000-0003-2848-103X
  • López Granados, Eduardo
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Yagüe, Jordi|||0000-0001-8210-1929
  • Alsina Manrique, Laia|||0000-0002-3559-0018
  • Juan, Manel|||0000-0002-3064-1648
  • Casals, Ferran|||0000-0002-8941-0369
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency characterized by recurrent infections, hypogammaglobulinemia and poor response to vaccines. Its diagnosis is made based on clinical and immunological criteria, after exclusion of other diseases that can cause similar phenotypes. Currently, less than 20% of cases of CVID have a known underlying genetic cause. We have analyzed whole-exome sequencing and copy number variants data of 36 children and adolescents diagnosed with CVID and healthy relatives to estimate the proportion of monogenic cases. We have replicated an association of CVID to p.C104R in TNFRSF13B and reported the second case of homozygous patient to date. Our results also identify five causative genetic variants in LRBA, CTLA4, NFKB1, and PIK3R1, as well as other very likely causative variants in PRKCD, MAPK8, or DOCK8 among others. We experimentally validate the effect of the LRBA stop-gain mutation which abolishes protein production and downregulates the expression of CTLA4, and of the frameshift indel in CTLA4 producing expression downregulation of the protein. Our results indicate a monogenic origin of at least 15-24% of the CVID cases included in the study. The proportion of monogenic patients seems to be lower in CVID than in other PID that have also been analyzed by whole exome or targeted gene panels sequencing. Regardless of the exact proportion of CVID monogenic cases, other genetic models have to be considered for CVID. We propose that because of its prevalence and other features as intermediate penetrancies and phenotypic variation within families, CVID could fit with other more complex genetic scenarios. In particular, in this work, we explore the possibility of CVID being originated by an oligogenic model with the presence of heterozygous mutations in interacting proteins or by the accumulation of detrimental variants in particular immunological pathways, as well as perform association tests to detect association with rare genetic functional variation in the CVID cohort compared to healthy controls.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy

  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Plaja Rustein, Alberto|||0000-0002-2398-1134
  • Bezdan, Daniela
  • Bosio, Mattia
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
LRBA deficiency was first described in 2012 as an autosomal recessive disorder caused by biallelic mutations in the LRBA gene (OMIM #614700). It was initially characterized as producing early-onset hypogammaglobulinemia, autoimmune manifestations, susceptibility to inflammatory bowel disease, and recurrent infection. However, further reports expanded this phenotype (including patients without hypogammaglobulinemia) and described LRBA deficiency as a clinically variable syndrome with a wide spectrum of clinical manifestations. We present the case of a female patient who presented with type 1 diabetes, psoriasis, oral thrush, and enlarged liver and spleen at the age of 8 months. She later experienced recurrent bacterial and viral infections, including pneumococcal meningitis and Epstein Barr viremia. She underwent two consecutive stem cell transplants at the age of 8 and 9 years, and ultimately died. Samples from the patient and her parents were subjected to whole exome sequencing, which revealed a homozygous 1-bp insertion in exon 23 of the patient's LRBA gene, resulting in frameshift and premature stop codon. The patient's healthy mother was heterozygous for the mutation and her father tested wild-type. This finding suggested that either one copy of the paternal chromosome 4 bore a deletion including the LRBA locus, or the patient inherited two copies of the mutant maternal LRBA allele. The patient's sequencing data showed a 1-Mb loss of heterozygosity region in chromosome 4, including the LRBA gene. Comparative genomic hybridization array of the patient's and father's genomic DNA yielded normal findings, ruling out genomic copy number abnormalities. Here, we present the first case of LRBA deficiency due to a uniparental disomy (UPD). In contrast to classical Mendelian inheritance, UPD involves inheritance of 2 copies of a chromosomal region from only 1 parent. Specifically, our patient carried a small segmental isodisomy of maternal origin affecting 1 Mb of chromosome 4.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings

  • Rudilla Salvador, Francesc
  • Franco Jarava, Clara
  • García Prat, Marina
  • Martín Nalda, Andrea
  • Rivière, Jacques
  • Vidal Pérez, Francisco
  • Cuscó Martín, Ivon
  • Serra Juhe, Clara
  • Baz Redón, Noelia
  • García-Patos Briones, Vicente
  • Pujol-Borrell, Ricardo
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
  • Fernández Cancio, Mónica
  • Aguiló Cucurull, Aina
Inmunodeficiencias primarias; Secuenciación de próxima generación; Secuenciación clínica del exoma, Immunodeficiències primàries; Seqüenciació de propera generació; Seqüenciació clínica d’exomes, Primary immunodeficiencies; Next generation sequencing; Clinical exome sequencing, Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders., This study was funded by Instituto de Salud Carlos III, grants PI14/00405 and PI17/00660, cofinanced by the European Regional Development Fund (ERDF).